Thrivent Financial for Lutherans
PNT

Thrivent Financial for Lutherans’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,106,042
Closed -$7.38M – 2559
2023
Q3 		$7.38M Buy
1,106,042
+144,527
+15% +$1.2M 0.02% 688
2023
Q2 		$8.71M Buy
+961,515
New +$8.48M 0.02% 687

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Thrivent Financial for Lutherans's PNT Position: Q4 2023 in Review

Thrivent Financial for Lutherans sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,106,042 shares — an estimated $7.38M sold.

Thrivent Financial for Lutherans first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $8.71M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Thrivent Financial for Lutherans reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 1,106,042 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $7.38M.
  • Thrivent Financial for Lutherans first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's POINT Biopharma Global Inc. Common Stock position peaked at $8.71M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2023, filed 14 Feb 2024.